MedPath

LY-3537021

Generic Name
LY-3537021

A Study of LY3537021 in Healthy Participants

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2022-07-06
Last Posted Date
2023-03-01
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
47
Registration Number
NCT05444569
Locations
🇸🇬

Lilly Centre for Clinical Pharmacology, Singapore, Singapore

A Study of LY3537021 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

Phase 1
Completed
Conditions
Healthy
Type 2 Diabetes Mellitus
Interventions
Drug: Placebo
First Posted Date
2020-10-14
Last Posted Date
2021-12-17
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
85
Registration Number
NCT04586907
Locations
🇸🇬

Lilly Centre for Clinical Pharmacology, Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath